Skip Nav Destination
Issues
1 March 2007
-
Cover Image
Cover Image
(A) The membrane fraction from control or MG132-treated HCT116 cells was subjected to immunoblot assay with antibodies against Bax or VDAC, a mitochondrial outer membrane protein. The result suggests that MG132 induces Bax translocation to the mitochondria. (B) HCT 116 cells expressing GFP-Bax were treated with MG132 and stained with Hoechst 33342. Long arrows denote cells with punctated GFP-Bax signals while short arrows denote the apoptotic nuclei. The result indicates a well correlated Bax translocation and apoptosis in the cells. (C) Cells treated as in (B) were counter-stained with MitoTracker Red. The result indicates that the punctated GFP-Bax signal is colocalized with that of mitochondria. (D) Time-dependent Bax translocation following the treatment with MG132 as indicated by the increases in cells with punctated GFP-Bax signals. For details, see Ding et al. in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Reviews
Spotlight on Molecular Profiling
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study
Uma T. Shankavaram; William C. Reinhold; Satoshi Nishizuka; Sylvia Major; Daisaku Morita; Krishna K. Chary; Mark A. Reimers; Uwe Scherf; Ari Kahn; Douglas Dolginow; Jeffrey Cossman; Eric P. Kaldjian; Dominic A. Scudiero; Emanuel Petricoin; Lance Liotta; Jae K. Lee; John N. Weinstein
Research Articles: Therapeutics, Targets, and Development
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs
Gigi N.C. Chiu; Lincoln A. Edwards; Anita I. Kapanen; Melina M. Malinen; Wieslawa H. Dragowska; Corinna Warburton; Ghania G. Chikh; Karen Y.Y. Fang; Sophia Tan; Jonathan Sy; Catherine Tucker; Dawn N. Waterhouse; Richard Klasa; Marcel B. Bally
The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo
Deryk Loo; Nancy Pryer; Peter Young; Tony Liang; Suzanne Coberly; Kathleen L. King; Key Kang; Penny Roberts; Mary Tsao; Xiaolin Xu; Beverly Potts; Jennie P. Mather
P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models
Kalpana S. Joshi; Maggie J. Rathos; Pravin Mahajan; Vilas Wagh; Satyendra Shenoy; Dimple Bhatia; Shailaja Chile; Meenakshi Sivakumar; Armin Maier; Heinz-Herbert Fiebig; Somesh Sharma
Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein
Collins A. Karikari; Indrajit Roy; Eric Tryggestad; Georg Feldmann; Clemencia Pinilla; Kate Welsh; John C. Reed; Elwood P. Armour; John Wong; Joseph Herman; Dinesh Rakheja; Anirban Maitra
Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells
Murielle Mimeault; Sonny L. Johansson; Ganesh Vankatraman; Eric Moore; Jean-Pierre Henichart; Patrick Depreux; Ming-Fong Lin; Surinder K. Batra
A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation
Anthea Hardcastle; Peter Tomlin; Clair Norris; Juliet Richards; Matthew Cordwell; Katherine Boxall; Martin Rowlands; Keith Jones; Ian Collins; Edward McDonald; Paul Workman; Wynne Aherne
Inhibition of heat shock protein 90 impairs epidermal growth factor–mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo
Sven A. Lang; Dagmar Klein; Christian Moser; Andreas Gaumann; Gabriel Glockzin; Marc H. Dahlke; Wolfgang Dietmaier; Ulrich Bolder; Hans J. Schlitt; Edward K. Geissler; Oliver Stoeltzing
Blockade of the phosphatidylinositol-3-kinase–Akt signaling pathway enhances the induction of apoptosis by microtubule-destabilizing agents in tumor cells in which the pathway is constitutively activated
Yusuke Fujiwara; Yoshihisa Hosokawa; Kazushi Watanabe; Susumu Tanimura; Kei-ichi Ozaki; Michiaki Kohno
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Jann N. Sarkaria; Lin Yang; Patrick T. Grogan; Gaspar J. Kitange; Brett L. Carlson; Mark A. Schroeder; Evanthia Galanis; Caterina Giannini; Wenting Wu; Eduard B. Dinca; C. David James
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.